Not available
Quote | Biofrontera AG (NASDAQ:BFRA)
Last: | $2.67 |
---|---|
Change Percent: | -9.49% |
Open: | $3.1 |
Close: | $2.67 |
High: | $3.1 |
Low: | $2.6 |
Volume: | 4,951 |
Last Trade Date Time: | 03/04/2022 04:54:38 pm |
News | Biofrontera AG (NASDAQ:BFRA)
Biofrontera (BFRA -3.4%) announced that the company decided to delist its American Depositary Shares (ADS) from the Nasdaq Capital Market. Concurrently, its reporting requirements with the U.S. Securities and Exchange Commission (SEC) will also come to an end. The decision followed its plans ...
Leverkusen, Germany, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera AG (the “Company”) (Nasdaq: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, decided today its American Depositary Shares (“ADS”) should be delisted from the N...
Message Board Posts | Biofrontera AG (NASDAQ:BFRA)
Subject | By | Source | When |
---|---|---|---|
* * $BFRA Video Chart 09-11-2020 * * | ClayTrader | investorshub | 09/11/2020 9:03:20 PM |
What's up here? This chart looks crazy. | muneeflo | investorshub | 09/11/2020 4:38:34 PM |
what a reversal from the highs today | $treet $inatra | investorshub | 09/11/2020 2:44:24 PM |
I WAIT FOR $55. LOL. IF $BFRA DOESN'T | otcmoneydoubler | investorshub | 09/11/2020 1:47:49 PM |
12-14 dollars. | dinogreeves | investorshub | 09/11/2020 12:40:16 PM |
News, Short Squeeze, Breakout and More Instantly...
Biofrontera AG Company Name:
BFRA Stock Symbol:
NASDAQ Market:
Leverkusen, Germany, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera AG (the “Company”) (Nasdaq: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, decided today its American Depositary Shares (“ADS”) should be delisted from the N...
Leverkusen, Germany, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (ISIN: DE0006046113) has been in mediation proceedings with Mr. Wilhelm K. T. Zours and Deutsche Balaton AG for a year in order to find a solution for the settlement of legal ...
Leverkusen, Germany, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the nine months ended September 30, 2021. K ...